Search Results - shohei+koide

3 Results Sort By:
Monobody R15 targets the nucleotide free state of RAS to block oncogenic signaling and transformation
Technology: Researchers at MUSC and NYU Langone Medical Center have identified a synthetic protein (R15) that selectively binds to the nucleotide-free state of the RAS proto-oncogene (apoRAS) and is the first experimental tool to selectively inhibit the signaling and oncogenic activity of selected oncogenic RAS mutants (Figure 1). The synthetic protein...
Published: 4/29/2024   |   Inventor(s): John O'Bryan, Shohei Koide, Akiko Koide
Keywords(s):  
Category(s): BioPharma
Improved Fibronectin Scaffolds for Artificial Antibody
Applications:This technology demonstrates the utility of the fibronectin type III domain as a scaffold to discover novel high affinity binding proteins. The fibronectin type III domain is small, stable and its structure has been well characterized making it an attractive system. This technology has application in drug discovery and design.
Published: 8/14/2023   |   Inventor(s): Shohei Koide
Keywords(s): Research Tool
Category(s): Research Tools
Stabilized Outersurface Protein A Fragment as a Lyme Disease Vaccine
ApplicationsLyme disease is a tick-borne infection caused by the spirochete Borrelia burgdorferi that can result in damages to joints, cardiovascular and nervous systems. Outsurface protein A (OspA) is a major surface antigen of Borrelia burgdorferi. Anti- OspA mAb has been shown to protect severe combined immunodeficiency mice from clinical symptoms...
Published: 5/7/2024   |   Inventor(s): Shohei Koide, Benjamin Luft, John Dunn, Catherine Lawson
Keywords(s): Vaccine
Category(s): Vaccines